Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Inovio: Q2 Earnings Snapshot AP - Wed Aug 12, 3:10PM CDT

Inovio: Q2 Earnings Snapshot

INO : 1.1500 (+5.50%)
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire - Wed Aug 12, 3:05PM CDT

PLYMOUTH MEETING, Pa. , Aug. 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
INOVIO to Report Second Quarter Financial Results on August 12, 2026 PR Newswire - Tue Aug 4, 3:05PM CDT

PLYMOUTH MEETING, Pa. , Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire - Wed Jul 29, 7:53PM CDT

PLYMOUTH MEETING, Pa. , July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

INO : 1.1500 (+5.50%)
INOVIO Announces Proposed Public Offering PR Newswire - Wed Jul 29, 3:01PM CDT

PLYMOUTH MEETING, Pa. , July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

INO : 1.1500 (+5.50%)
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm PR Newswire - Thu Jun 4, 3:37PM CDT

NEW YORK , June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ:...

INO : 1.1500 (+5.50%)
INOVIO to Participate in Upcoming Scientific and Investor Conferences PR Newswire - Thu May 28, 7:05AM CDT

PLYMOUTH MEETING, Pa. , May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
MarketBeat.com
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances MarketBeat - Mon May 25, 1:02PM CDT

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young...

INO : 1.1500 (+5.50%)
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China PR Newswire - Thu May 21, 3:05PM CDT

PLYMOUTH MEETING, Pa. , May 21, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
Inovio: Q1 Earnings Snapshot AP - Wed May 13, 3:13PM CDT

Inovio: Q1 Earnings Snapshot

INO : 1.1500 (+5.50%)

Barchart Exclusives

Target Option Trade: Selling High Volatility Before Earnings Barchart - 7 minutes ago
Selling put options before a company's earnings announcement can be a valid strategy for options traders seeking to capitalize on higher than normal volatility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.